AAAAAA

   
Results: 1-11 |
Results: 11
INSULIN-LIKE-GROWTH-FACTOR I (IGF-I) SERUM LEVEL MODIFICATIONS DURINGTRANSDERMAL ESTRADIOL TREATMENT IN POSTMENOPAUSAL WOMEN - A POSSIBLE BIMODAL EFFECT DEPENDING ON BASAL IGF-I VALUES
Authors: CAMPAGNOLI C BIGLIA N CANTAMESSA C LESCA L LATANO MR SISMONDI P
Citation: C. Campagnoli et al., INSULIN-LIKE-GROWTH-FACTOR I (IGF-I) SERUM LEVEL MODIFICATIONS DURINGTRANSDERMAL ESTRADIOL TREATMENT IN POSTMENOPAUSAL WOMEN - A POSSIBLE BIMODAL EFFECT DEPENDING ON BASAL IGF-I VALUES, Gynecological endocrinology, 12(4), 1998, pp. 259-266
INSULIN-LIKE GROWTH-FACTOR-I AND RISK OF BREAST-CANCER
Authors: CAMPAGNOLI C AMBROGGIO S BIGLIA N PERIS C SISMONDI P
Citation: C. Campagnoli et al., INSULIN-LIKE GROWTH-FACTOR-I AND RISK OF BREAST-CANCER, Lancet, 352(9126), 1998, pp. 488-489
CLINICAL AND ETHICAL ISSUES IN THE DIAGNOSIS OF HEREDITARY BREAST-CANCER (REVIEW)
Authors: PONZONE R GIAI M ROAGNA R SGRO L BIGLIA N WELCH H SISMONDI P
Citation: R. Ponzone et al., CLINICAL AND ETHICAL ISSUES IN THE DIAGNOSIS OF HEREDITARY BREAST-CANCER (REVIEW), International journal of oncology, 10(2), 1997, pp. 323-328
SUBFRACTIONS OF PROSTATE-SPECIFIC ANTIGEN DIFFER IN SERUM OF NORMAL WOMEN AND WOMEN WITH MALIGNANT AND BENIGN BREAST DISEASES
Authors: GIAI M PONZONE R ROAGNA R SGRO L BIGLIA N BORCHERT GH DIAMANDIS EP SISMONDI P
Citation: M. Giai et al., SUBFRACTIONS OF PROSTATE-SPECIFIC ANTIGEN DIFFER IN SERUM OF NORMAL WOMEN AND WOMEN WITH MALIGNANT AND BENIGN BREAST DISEASES, Breast, 6(5), 1997, pp. 919-919
HORMONE REPLACEMENT THERAPY AND BREAST-CANCER RISK
Authors: CAMPAGNOLI C BIGLIA N SISMONDI P
Citation: C. Campagnoli et al., HORMONE REPLACEMENT THERAPY AND BREAST-CANCER RISK, JAMA, the journal of the American Medical Association, 275(15), 1996, pp. 1159-1159
MISPLACED CONFIDENCES
Authors: CAMPAGNOLI C CANTAMESSA C LESCA L SISMONDI P BIGLIA N
Citation: C. Campagnoli et al., MISPLACED CONFIDENCES, Fertility and sterility, 66(5), 1996, pp. 859-860
CRITICAL-REVIEW OF THE ARTICLE BY COLDITZ ET-AL ON THE USE OF ESTROGENS AND PROGESTINS AND THE RISK OF BREAST-CANCER IN POSTMENOPAUSAL WOMEN
Authors: SISMONDI P BIGLIA N
Citation: P. Sismondi et N. Biglia, CRITICAL-REVIEW OF THE ARTICLE BY COLDITZ ET-AL ON THE USE OF ESTROGENS AND PROGESTINS AND THE RISK OF BREAST-CANCER IN POSTMENOPAUSAL WOMEN, Pharmacological research, 32(6), 1995, pp. 329-330
POTENTIAL IMPACT ON BREAST-CANCER RISK OF CIRCULATING INSULIN-LIKE GROWTH-FACTOR-I MODIFICATIONS INDUCED BY ORAL HRT IN MENOPAUSE
Authors: CAMPAGNOLI C BIGLIA N PERIS C SISMONDI P
Citation: C. Campagnoli et al., POTENTIAL IMPACT ON BREAST-CANCER RISK OF CIRCULATING INSULIN-LIKE GROWTH-FACTOR-I MODIFICATIONS INDUCED BY ORAL HRT IN MENOPAUSE, Gynecological endocrinology, 9(1), 1995, pp. 67-74
ANDROGENIC PROGESTOGENS OPPOSE THE DECREASE OF INSULIN-LIKE GROWTH-FACTOR-I SERUM LEVEL INDUCED BY CONJUGATED ESTROGENS IN POSTMENOPAUSAL WOMEN - PRELIMINARY-REPORT
Authors: CAMPAGNOLI C BIGLIA N LANZA MG LESCA L PERIS C SISMONDI P
Citation: C. Campagnoli et al., ANDROGENIC PROGESTOGENS OPPOSE THE DECREASE OF INSULIN-LIKE GROWTH-FACTOR-I SERUM LEVEL INDUCED BY CONJUGATED ESTROGENS IN POSTMENOPAUSAL WOMEN - PRELIMINARY-REPORT, Maturitas, 19(1), 1994, pp. 25-31
METABOLIC EFFECTS OF TAMOXIFEN IN POSTMENOPAUSE
Authors: SISMONDI P BIGLIA N GIAI M SGRO L CAMPAGNOLI C
Citation: P. Sismondi et al., METABOLIC EFFECTS OF TAMOXIFEN IN POSTMENOPAUSE, Anticancer research, 14(5B), 1994, pp. 2237-2244
DIFFERENTIAL-EFFECTS OF ORAL CONJUGATED ESTROGENS AND TRANSDERMAL ESTRADIOL ON INSULIN-LIKE GROWTH-FACTOR-1, GROWTH-HORMONE AND SEX-HORMONEBINDING GLOBULIN SERUM LEVELS
Authors: CAMPAGNOLI C BIGLIA N ALTARE F LANZA MG LESCA L CANTAMESSA C PERIS C FIORUCCI GC SISMONDI P
Citation: C. Campagnoli et al., DIFFERENTIAL-EFFECTS OF ORAL CONJUGATED ESTROGENS AND TRANSDERMAL ESTRADIOL ON INSULIN-LIKE GROWTH-FACTOR-1, GROWTH-HORMONE AND SEX-HORMONEBINDING GLOBULIN SERUM LEVELS, Gynecological endocrinology, 7(4), 1993, pp. 251-258
Risultati: 1-11 |